Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07061951 |
| Title | Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | National Cancer Institute (NCI) |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope Comprehensive Cancer Center | RECRUITING | Duarte | California | 91010 | United States | Details |
| City of Hope at Irvine Lennar | RECRUITING | Irvine | California | 92618 | United States | Details |
| Dana-Farber Cancer Institute | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
| UNC Lineberger Comprehensive Cancer Center | RECRUITING | Chapel Hill | North Carolina | 27599 | United States | Details |
| University of Pittsburgh Cancer Institute (UPCI) | RECRUITING | Pittsburgh | Pennsylvania | 15232 | United States | Details |